Effects on re-endothelialisation with Bydureon treatment add on to Insulin versus Insulin alone, both in combination with Metformin in type 2 diabetic subjects (Rebuild Study).
Phase of Trial: Phase III
Latest Information Update: 15 Sep 2016
At a glance
- Drugs Exenatide (Primary) ; Exenatide (Primary) ; Insulin aspart; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms Rebuild
- 07 Jun 2017 Biomarkers information updated
- 31 Aug 2016 Planned End Date changed from 1 Apr 2018 to 1 Apr 2019.
- 31 Aug 2016 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.